TradeOrgs
  • 🇮🇳 India
  • 🇺🇸 US
  • Screener
  • Backtest
  • Watchlist
  • Signals
  • Portfolio
  • Insights
  • Connect
Sign in
RELIANCE₹1,313.20▼ 0.75%TCS₹2,298.00▲ 2.08%HDFCBANK₹725.05▼ 6.76%ICICIBANK₹1,411.90▼ 3.31%INFY₹1,130.00▲ 3.95%HINDUNILVR₹2,028.00▼ 5.22%ITC₹271.65▼ 3.91%SBIN₹1,048.00▼ 1.13%BHARTIARTL₹1,941.70▼ 0.34%KOTAKBANK₹397.35▲ 4.00%LT₹4,081.00▲ 6.31%AXISBANK₹1,251.00▼ 0.40%ASIANPAINT₹2,625.20▼ 2.50%MARUTI₹13,809.00▲ 2.18%AAPL$317.61▼ 2.75%MSFT$481.14▲ 19.60%GOOGL$341.22▼ 3.06%AMZN$261.20▲ 4.48%NVDA$218.03▲ 7.26%META$544.51▼ 15.69%TSLA$341.10▼ 7.70%BRK-B$499.37▲ 1.65%JPM$357.57▲ 5.52%V$368.75▲ 2.27%
RELIANCE₹1,313.20▼ 0.75%TCS₹2,298.00▲ 2.08%HDFCBANK₹725.05▼ 6.76%ICICIBANK₹1,411.90▼ 3.31%INFY₹1,130.00▲ 3.95%HINDUNILVR₹2,028.00▼ 5.22%ITC₹271.65▼ 3.91%SBIN₹1,048.00▼ 1.13%BHARTIARTL₹1,941.70▼ 0.34%KOTAKBANK₹397.35▲ 4.00%LT₹4,081.00▲ 6.31%AXISBANK₹1,251.00▼ 0.40%ASIANPAINT₹2,625.20▼ 2.50%MARUTI₹13,809.00▲ 2.18%AAPL$317.61▼ 2.75%MSFT$481.14▲ 19.60%GOOGL$341.22▼ 3.06%AMZN$261.20▲ 4.48%NVDA$218.03▲ 7.26%META$544.51▼ 15.69%TSLA$341.10▼ 7.70%BRK-B$499.37▲ 1.65%JPM$357.57▲ 5.52%V$368.75▲ 2.27%

TradeOrgs shows market information and analyzes your own trading history. It does not place trades and is not investment advice.

Prices and listings are for information only. We are read-only against your broker account.

Technical signals (RSI, MACD, etc.) are educational readouts of public indicators — not recommendations.

Privacy Policy·© 2026 TradeOrgs

← US stocks

🇺🇸ASTH

Astrana Health Inc. - Common Stock

NASDAQ
$39.24
▼ $5.31 (-11.9%)
Live· just now
delayed feed · not for order timing

Price history · 20-day (cyan) / 50-day (purple) avg

as of 20 Aug 2026
H $51.60L $18.08+111.1%
$51.6$44.9$38.19$31.49$24.78$18.08$39.24
RSI (14)
Intraday · 15-minStrong sell-50RSI 46DowntrendMACD Bearishfor day-trading context — not advice

Technical signal

Neutral-5
RSI (14)50
oversold 30overbought 70
Trend
Downtrend
MACD
Bullish
Bollinger
Within bands
vs 20-day
above
vs 50-day
below
vs 200-day
above
Support
$33.92
Resistance
$42.14
  • Price is below its 50-day average (medium-term weakness).
  • Price is above its 200-day average (long-term uptrend).

Signal backtest · 2025-11-13 → 2026-08-20

Strategy return
+9.4%
Buy & hold
+79.1%
Trades
4
Win rate
25%

$100,000.00 invested would be worth $109,412.90 (+9.4%) · Full backtester →

Hypothetical: go long when the signal turns Buy, exit when it turns Sell. Past indicator behavior is not a prediction — educational only, not advice.

About Astrana Health, Inc.· Medical Care Facilities

source: yahoo

Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network includes primary care physicians, specialist physicians and extenders, and hospitalists. The company serves patients primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was founded in 1992 and is headquartered in Alhambra, California.

Sector
Healthcare
Industry
Medical Care Facilities
Employees
3,000
Headquarters
Alhambra, United States
www.astranahealth.com ↗

Fundamentals

source: yahoo
Market cap
$1.95B
P/E
47.9
P/B
2.3
EPS
$0.82
Div yield
—
Profit margin
1.1%
ROE
6.9%
Debt / Equity
1.64
Beta
0.90
52-week range
$18.08 – $51.60
52-week low · $18.0863% of rangehigh · $51.60

Fundamental data is informational only — not investment advice.

Recent news

News sentiment:▲ Positive3↑ · 0↓ · 5–
  • 2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm— Neutral
    StockStory · 16 Aug 2026
  • 5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call— Neutral
    StockStory · 15 Aug 2026
  • Astrana Health (ASTH) Q2 2026 Earnings Call Transcript— Neutral
    Motley Fool · 13 Aug 2026
  • Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating

Educational technical indicators — not investment advice. TradeOrgs does not place trades.

▲ Positive
MT Newswires · 11 Aug 2026
  • ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook▲ Positive
    StockStory · 10 Aug 2026
  • Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress— Neutral
    Simply Wall St. · 07 Aug 2026
  • Sentiment is a keyword-based read of the headline — a rough signal, not advice.